RM
ruben mesa
Atrium Health Wake Forest Baptist
Research areas: Medicine · Hematology · Myeloproliferative Neoplasms: Diagnosis and Treatment · Acute Myeloid Leukemia Research · Chronic Lymphocytic Leukemia Research
0000-0001-5880-7972
Employment
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (153)
- Efficacy and Safety Outcomes With Pacritinib Versus Ruxolitinib in Patients With Myelofibrosis and Thrombocytopenia: Analysis of Data From the Phase III PERSIST-2 Study Save
- Association Between Transfusion Status, Hemoglobin Levels, and Patient‐Reported Outcomes in Myelofibrosis: A Post Hoc Clinical Trial Analysis Save
- Supplementary Figure S1 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis Save
- Supplementary Figure S2 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis Save
- Supplementary Figure S3 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis Save
- Supplementary Figure S4 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis Save
- Supplementary Figure S5 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis Save
- Supplementary Figure S6 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis Save
- Supplementary Figure S7 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis Save
- Supplementary Figure S8 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis Save
- Supplementary Figure S9 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis Save
- Supplementary Table S1 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis Save
- Supplementary Table S2 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis Save
- Supplementary Table S3 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis Save
- Supplementary Table S4 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis Save
- Time Without Transfusion Reliance (TWiTR): Integrating Survival Quality Into Myelofibrosis Treatment Strategies Based on the Phase 3 SIMPLIFY‐1, SIMPLIFY‐2, and MOMENTUM Trials Save
- National Cancer Institute comprehensive cancer centers: Significant improvement in mortality and symptom control, further opportunities remain toward health equity Save
- Anemia in Myelofibrosis: A Focus on Proactive Management and the Role of Momelotinib Save
- Data from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis Save
- Supplementary Figure S1 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis Save